Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (402)

121

Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2 : a computational approach for anti-COVID-19 drug discovery

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Arunkumar, M. | Gunaseelan, S. | Kubendran Aravind, M. | +6

122

Consensus statement and recommendations on the treatment of COVID-19 : 2021 update

enthalten in: Journal of the Chinese Medical Association : JCMA | 2022

von Ko, H. | Yu, W. | Pan, S. | +7

123

The impact of therapeutics on mortality in hospitalised patients with COVID-19 : systematic review and meta-analyses informing the European Respiratory Society living guideline

enthalten in: European respiratory review : an official journal of the European Respiratory Society | 2021

von Crichton, M. | Goeminne, P. | Tuand, K. | +5

124

The need for a multi-level drug targeting strategy to curb the COVID-19 pandemic

enthalten in: Frontiers in bioscience (Landmark edition) | 2021

von Kontoghiorghes, G. | Fetta, S. | Kontoghiorghe, C.

125

COVID-19 : potential therapeutics for pediatric patients

enthalten in: Pharmacological reports : PR | 2021

von Younis, N. | Zareef, R. | Fakhri, G. | +3

126

Host-modifying drugs against COVID-19 : some successes, but not yet the breakthrough

enthalten in: Environmental microbiology | 2021

von Brüssow, H.

127

Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection

enthalten in: Emerging microbes & infections | 2021

von Ye, Z. | Yuan, S. | Chan, J. | +13

128

Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for the treatment of hyperinflammation

enthalten in: Turkish journal of medical sciences | 2021

von Tufan, A. | Matucci-Cerinic, M.

129

A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality

enthalten in: Emerging microbes & infections | 2021

von Camelo, S. | Latil, M. | Agus, S. | +4

130

Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients

enthalten in: Journal of medical virology | 2021

von Kalantari, S. | Fard, S. | Maleki, D. | +4